Dr. Abdelrahman Alshehri
panellist
Abdulrahman Alshehri
Consultant,
Oncologisit
Oncology institute
Johns Hopkins Aramco Healthcare
Dhahran,
Kingdom of Saudi Arabia
09:45 –10:30
Friday 3-5-2024 Day 1
Role of anthracyclines in early breast cancer
- When to omit anthracyclines in(neo) adjuvant therapy of HER2-negative breast cancer
When to use anthracyclines in (neo) adjuvant therapy of HER2-positive breast cancer
Moderator:
Dr. Meteeb Alfohaidi
Panel:
